Alberti MO, Srivatsan SN, Shao J, McNulty SN, Chang GS, Miller CA, Dunlap JB et al (2018) Discriminating a common somatic ASXL1 mutation (c.1934dup; p. G646Wfs*12) from artifact in myeloid malignancies using NGS. Leukemia 32(8):1874–1878
Amberger JS, Bocchini CA, Scott AF, Hamosh A (2019) OMIM.org: leveraging knowledge across phenotype-gene relationships. Nucleic Acids Res 47(D1):D1038–D1043
Avramović V, Frederiksen SD, Brkić M, Tarailo-Graovac M (2021) Driving mosaicism: somatic variants in reference population databases and effect on variant interpretation in rare genetic disease. Hum Genomics 15(1):71
Brunet T, Berutti R, Dill V, Hecker JS, Choukair D, Andres S, Deschauer M et al (2022) Clonal hematopoiesis as a pitfall in germline variant interpretation in the context of Mendelian disorders. Hum Mol Genet. https://doi.org/10.1093/hmg/ddac034
Carlston CM, O’Donnell-Luria AH, Underhill HR, Cummings BB, Weisburd B, Minikel EV, Birnbaum DP et al (2017) Pathogenic ASXL1 somatic variants in reference databases complicate germline variant interpretation for Bohring-Opitz syndrome. Hum Mutat 38(5):517–523
Ciptasari U, van Bokhoven H (2020) The phenomenal epigenome in neurodevelopmental disorders. Hum Mol Genet 29(R1):R42-50
Gudmundsson S, Karczewski KJ, Francioli LC, Tiao G, Cummings BB, Alföldi J, Wang Q et al (2021) Addendum: the mutational constraint spectrum quantified from variation in 141,456 humans. Nature. https://doi.org/10.1038/s41586-021-03758-y
Gudmundsson S, Moriel S-B, Nicholas AW, William P, Julia KG, Matthew S, Genome Aggregation Database Consortium, Heidi LR, Daniel GM, Anne O-L (2022) Variant interpretation using population databases: lessons from gnomAD. Hum Mutat 43(8):1012–1030
Karczewski KJ, Francioli LC, Tiao G, Cummings BB, Alföldi J, Wang Q, Collins RL et al (2020) The mutational constraint spectrum quantified from variation in 141,456 humans. Nature 581(7809):434–443
Lek M, Karczewski KJ, Minikel EV, Samocha KE, Banks E, Fennell T, O’Donnell-Luria AH et al (2016) Analysis of protein-coding genetic variation in 60,706 humans. Nature 536(7616):285–291
Paul AM, Madhavan RP, Rakesh K (2021) Prognostic significance of dysregulated epigenomic and chromatin modifiers in cervical cancer. Cells. https://doi.org/10.3390/cells10102665
Pich O, Reyes-Salazar I, Gonzalez-Perez A, Lopez-Bigas N (2022) Discovering the drivers of clonal hematopoiesis. Nat Commun 13(1):4267
Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW et al (2015) Standards and Guidelines for the Interpretation of Sequence Variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology. Genet Med: Off J Am Coll Med Genet 17(5):405–424
Samocha KE, Robinson EB, Sanders SJ, Stevens C, Sabo A, McGrath LM, Kosmicki JA et al (2014) A framework for the interpretation of de Novo mutation in human disease. Nat Genet 46(9):944–950
Shen W, Heeley JM, Carlston CM, Acuna-Hidalgo R, Nillesen WM, Dent KM, Douglas GV et al (2017) The spectrum of DNMT3A variants in Tatton-Brown-Rahman syndrome overlaps with that in hematologic malignancies. Am J Med Genet A 173(11):3022–3028
Silver AJ, Bick AG, Savona MR (2021) Germline risk of clonal haematopoiesis. Nat Rev Genet 22(9):603–617
Urreizti R, Gürsoy S, Castilla-Vallmanya L, Cunill G, Rabionet R, Erçal D, Grinberg D, Balcells S (2018) The ASXL1 mutation p.Gly646Trpfs*12 found in a Turkish boy with Bohring-Opitz syndrome. Clin Case Rep 6(8):1452–1456
留言 (0)